SI1592416T1 - Maščobne kisline s srednjo dolžino verige, gliceridi in analogi kot stimulatorji eritropoeze - Google Patents

Maščobne kisline s srednjo dolžino verige, gliceridi in analogi kot stimulatorji eritropoeze

Info

Publication number
SI1592416T1
SI1592416T1 SI200431064T SI200431064T SI1592416T1 SI 1592416 T1 SI1592416 T1 SI 1592416T1 SI 200431064 T SI200431064 T SI 200431064T SI 200431064 T SI200431064 T SI 200431064T SI 1592416 T1 SI1592416 T1 SI 1592416T1
Authority
SI
Slovenia
Prior art keywords
erythropoiesis
stimulators
glycerides
analogues
medium
Prior art date
Application number
SI200431064T
Other languages
English (en)
Inventor
Christopher Penney
Lyne Gagnon
Pierre Laurin
Boulos Zacharie
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of SI1592416T1 publication Critical patent/SI1592416T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200431064T 2003-02-07 2004-02-06 Maščobne kisline s srednjo dolžino verige, gliceridi in analogi kot stimulatorji eritropoeze SI1592416T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44545403P 2003-02-07 2003-02-07
PCT/GB2004/000457 WO2004069237A1 (en) 2003-02-07 2004-02-06 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
EP04708802A EP1592416B1 (en) 2003-02-07 2004-02-06 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis

Publications (1)

Publication Number Publication Date
SI1592416T1 true SI1592416T1 (sl) 2009-06-30

Family

ID=32850990

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431064T SI1592416T1 (sl) 2003-02-07 2004-02-06 Maščobne kisline s srednjo dolžino verige, gliceridi in analogi kot stimulatorji eritropoeze

Country Status (28)

Country Link
US (1) US9682054B2 (sl)
EP (1) EP1592416B1 (sl)
JP (1) JP5390070B2 (sl)
KR (1) KR101120775B1 (sl)
CN (1) CN100427081C (sl)
AP (1) AP2005003367A0 (sl)
AR (1) AR043120A1 (sl)
AT (1) ATE419846T1 (sl)
AU (1) AU2004210193B2 (sl)
BR (1) BRPI0407276A (sl)
CA (1) CA2515160C (sl)
CY (1) CY1108963T1 (sl)
DE (2) DE04708802T1 (sl)
DK (1) DK1592416T3 (sl)
EA (1) EA009939B1 (sl)
ES (1) ES2255467T3 (sl)
IL (1) IL170057A (sl)
JO (1) JO2705B1 (sl)
MA (1) MA27664A1 (sl)
MX (1) MXPA05008382A (sl)
MY (1) MY140913A (sl)
NO (1) NO334085B1 (sl)
NZ (1) NZ541593A (sl)
PT (1) PT1592416E (sl)
SI (1) SI1592416T1 (sl)
TN (1) TNSN05189A1 (sl)
WO (1) WO2004069237A1 (sl)
ZA (1) ZA200506246B (sl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ528690A (en) 2001-04-18 2005-08-26 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
JP2007532629A (ja) * 2004-04-15 2007-11-15 キアスマ， インコーポレイテッド 生物学的障壁を横切る透過を促進し得る組成物
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
EP2314617B1 (en) 2004-07-23 2015-06-24 Acceleron Pharma Inc. ActRII receptor polypeptides
JP2008511553A (ja) * 2004-09-03 2008-04-17 プロメティック バイオサイエンシズ インコーポレーテッド 免疫調節活性および化学防護活性を有する置換型プリニル誘導体ならびにその単独使用または中鎖長の脂肪酸もしくはグリセリドとの併用
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
PT1804780E (pt) * 2004-10-01 2012-01-19 Prometic Biosciences Inc Álcoois gordos com comprimento médio da cadeia como estimuladores da hematopoiese
EP1973559B1 (en) 2005-11-23 2013-01-09 Acceleron Pharma Inc. Activin-actriia antagonists and uses for promoting bone growth
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
CA2677007A1 (en) 2007-02-01 2008-08-07 Acceleron Pharma Inc. Activin-actriia antagonists and uses for treating or preventing breast cancer
TW201803890A (zh) 2007-02-02 2018-02-01 艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
CA3039330C (en) 2007-02-09 2021-11-09 Acceleron Pharma Inc. Activin-actriia antagonists and uses for promoting bone growth in cancer patients
CN103877564A (zh) 2007-09-18 2014-06-25 阿塞勒隆制药公司 活化素-actriia拮抗剂和减少或抑制fsh分泌的用途
MX338513B (es) 2007-11-02 2016-04-20 Prometic Pharma Smt Ltd Acidos grasos de longitud de cadena mediana y gliceridos como agentes de nefroprotección.
BRPI0821395A2 (pt) * 2007-12-19 2015-06-16 Prometic Biosciences Inc Triglicerídeos, sais e ácidos graxos de cadeia média em combinação com gemcitabina para tratamento de câncer pancreático
DK2340031T3 (da) 2008-08-14 2019-07-15 Acceleron Pharma Inc Gdf-fanger til anvendelse ved behandling af anæmi
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
JP5623406B2 (ja) 2008-09-17 2014-11-12 キアズマ インコーポレイテッド 医薬組成物および関連する送達方法
MX2011013172A (es) 2009-06-08 2012-04-02 Acceleron Pharma Inc Metodos para aumentar adipocitos termogenicos.
KR20120028358A (ko) 2009-06-12 2012-03-22 악셀레론 파마 인코포레이티드 절두된 ＡｃｔＲＩＩＢ-ＦＣ 융합 단백질
IL287990B (en) * 2009-08-13 2022-07-01 Acceleron Pharma Inc Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
EP3332796A1 (en) 2009-11-17 2018-06-13 Acceleron Pharma Inc. Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
CA2817008A1 (en) 2010-11-08 2012-05-18 Acceleron Pharma Inc. Actriia binding agents and uses thereof
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法
KR20210091358A (ko) 2012-11-02 2021-07-21 셀진 코포레이션 골 및 다른 장애를 치료하기 위한 액티빈-actrii 길항제 및 용도
CN102973922B (zh) * 2012-12-18 2016-02-03 华东理工大学 一种融合蛋白的应用
WO2015192111A1 (en) 2014-06-13 2015-12-17 Acceleron Pharma, Inc. Methods and compositions for treating ulcers
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
PT3227675T (pt) 2014-12-03 2023-05-30 Celgene Corp Antagonistas da ativina-actrii e utilizações para tratamento da síndrome mielodisplásica
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
US20170021029A1 (en) * 2015-04-15 2017-01-26 Jeffrey Charles Raber Topical formulations and uses
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US6060459A (en) 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
US5011852A (en) 1988-07-25 1991-04-30 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
JP3014119B2 (ja) * 1990-05-28 2000-02-28 雪印乳業株式会社 直腸投与用赤血球造血剤
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
ATE147976T1 (de) * 1991-01-15 1997-02-15 Hemosphere Inc Protein nanomatrizen und verfahren zur herstellung
JPH05163160A (ja) 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
US5214035A (en) 1992-04-16 1993-05-25 Hoechst-Roussel Agri-Vet Company Thixotropic formulations
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
WO1995030413A1 (fr) * 1994-05-10 1995-11-16 The Kitasato Institute Accelerateur de proliferation de cellules souches hematopoietiques
US5470861A (en) 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5549905A (en) 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
IT1275802B1 (it) 1994-11-03 1997-10-17 Hoffmann La Roche Composizione di interferone
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
AUPN933396A0 (en) 1996-04-17 1996-05-09 Pfizer Pty Limited Non-aqueuos oral-drench compositions containing avermectin compounds
US5851534A (en) 1996-05-03 1998-12-22 Dynagen, Inc. Methods for prevention and/or treatment of neutropenia
JPH10265380A (ja) 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
AU9221698A (en) * 1997-09-04 1999-03-22 Biozone Laboratories, Inc. Oral liposomal delivery system
AU752802C (en) * 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
AU1416199A (en) 1997-11-19 1999-06-07 Hercules Incorporated Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
DE69833333T2 (de) 1997-11-20 2006-10-19 Jhon, Gil Ja Pharmazeutische zusammensetzung enthaltend geweihextrakte von cervus nippon mit wachstumsstimulierender aktivität auf hematopoietische stammzellen und megakaryozyten
PT937456E (pt) * 1998-02-23 2004-10-29 Cilag Ag Int Dispersao lipossomal de eritropoietina
EP1062952B1 (en) 1998-03-11 2003-08-06 Grelan Pharmaceutical Co., Ltd. Bubbling enteric preparations
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6479540B1 (en) 1999-09-27 2002-11-12 Sonus Pharmaceuticals, Inc. Compositions of tocol-soluble therapeutics
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
WO2001095914A1 (en) 2000-06-14 2001-12-20 William Leslie Porter Lipids for modulating immune response
US6967028B2 (en) 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
IL142535A0 (en) 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
NZ528690A (en) * 2001-04-18 2005-08-26 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
US20040052836A1 (en) 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
US6725510B1 (en) 2003-04-25 2004-04-27 Almetta Clyburn Inclining coffin
KR101120813B1 (ko) 2003-07-25 2012-03-23 프로메틱 바이오사이언시즈 인코포레이티드 중-쇄 지방산 금속염의 제조 방법
JP2008511553A (ja) 2004-09-03 2008-04-17 プロメティック バイオサイエンシズ インコーポレーテッド 免疫調節活性および化学防護活性を有する置換型プリニル誘導体ならびにその単独使用または中鎖長の脂肪酸もしくはグリセリドとの併用
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis

Also Published As

Publication number Publication date
JO2705B1 (ar) 2014-03-15
US9682054B2 (en) 2017-06-20
TNSN05189A1 (en) 2007-06-11
KR101120775B1 (ko) 2012-04-18
PT1592416E (pt) 2009-04-03
AR043120A1 (es) 2005-07-20
KR20050118671A (ko) 2005-12-19
MXPA05008382A (es) 2005-11-04
US20060128800A1 (en) 2006-06-15
NO20053994D0 (no) 2005-08-26
AP2005003367A0 (en) 2005-09-30
WO2004069237A1 (en) 2004-08-19
EP1592416A1 (en) 2005-11-09
CN1753665A (zh) 2006-03-29
JP2006516987A (ja) 2006-07-13
DE602004018902D1 (de) 2009-02-26
NZ541593A (en) 2009-05-31
EP1592416B1 (en) 2009-01-07
EA009939B1 (ru) 2008-04-28
DE04708802T1 (de) 2006-06-22
ATE419846T1 (de) 2009-01-15
CA2515160C (en) 2013-01-08
ES2255467T3 (es) 2009-05-01
IL170057A (en) 2011-09-27
AU2004210193B2 (en) 2007-07-12
EA200501267A1 (ru) 2006-02-24
BRPI0407276A (pt) 2006-01-31
MA27664A1 (fr) 2005-12-01
CA2515160A1 (en) 2004-08-19
CY1108963T1 (el) 2014-07-02
NO334085B1 (no) 2013-12-09
DK1592416T3 (da) 2009-04-20
ZA200506246B (en) 2006-12-27
ES2255467T1 (es) 2006-07-01
CN100427081C (zh) 2008-10-22
AU2004210193A1 (en) 2004-08-19
MY140913A (en) 2010-01-29
NO20053994L (no) 2005-10-06
JP5390070B2 (ja) 2014-01-15

Similar Documents

Publication Publication Date Title
SI1592416T1 (sl) Maščobne kisline s srednjo dolžino verige, gliceridi in analogi kot stimulatorji eritropoeze
HUP0303817A3 (en) Medium-chain length fatty acids, glycerides and analogues as neutrophile survival and activation factors and pharmaceutical compositions containing them
EP1685218A4 (en) Fatty acid esters and their use
PL377614A1 (pl) Kompozycje zawierające kwasy tłuszczowe i aminokwasy
AU2003202259A8 (en) Lipid compositions, production thereof and of esters
IL183246A0 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
IL158131A0 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
PL1753852T3 (pl) Kompozycje o własnościach wspomagających zdrowie i odżywianie zawierające interestryfikowane lipidy i estry fitosteroli, i odpowiednie sposoby
TW200504198A (en) Glyceride compositions and methods of making and using same
EP1801096A4 (en) POLYGLYCERIN FUEL ACID AND THE COMPOSITIONS CONTAINING THEREOF
IL176054A0 (en) Oil or fat composition containing phospholipids and long-chain polyunsaturated fatty acid supplying compound and food using the same
EP1500645A4 (en) ASTAXANTHINE FATTY ACID ESTERS WITH MEDIUM CHAIN LENGTH, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THE ESTER
EP1709952B8 (en) Composition containing polyglycerol/medium-chain fatty acid ester
EP1659848A4 (en) FATS AND FAT COMPOSITIONS WITH LOW TRANS-FATTY ACID CONTENT AND PROCESS FOR THEIR PREPARATION
HK1074792A1 (en) An anti-rheumatism medicament and method to prepare thereof
HK1087007A1 (en) Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum- glucose-lowering and serum-lipid-lowering activity
HK1097514A1 (en) Preparation of metal salts of medium-chain fatty acids
TWI339586B (en) Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
EP1617830A4 (en) ESTERIFIED FATTY ACID COMPOSITION
IL181684A0 (en) Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
AU2003271049A8 (en) Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin
HK1111358A1 (en) Medium-chain length fatty alcohols as stimulators of hematopoiesis
EP1640383A4 (en) ASPARAGIN / FATTY ACID AMID WITH DISIALOUNDECASACCHARIDE CHAIN AND THIS INCLUDING MEDICAMENT
EP1662912A4 (en) EDIBLE MIXTURE AND MANUFACTURING METHOD THEREFOR